| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/30/2007 | EP1790727A2 Proteins and nucleic acids encoding same |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790724A1 Knockout nonhuman animal |
| 05/30/2007 | EP1790720A1 Polypeptide having activity of unsaturating omega3-fatty acid, polynucleotide coding for the polypeptide and use thereof |
| 05/30/2007 | EP1790717A2 Compositions and methods for the identification of lung tumor cells |
| 05/30/2007 | EP1790716A1 Uses of the FcRn receptor |
| 05/30/2007 | EP1790664A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/30/2007 | EP1790663A1 Monoclonal antibody(ad5-10) against tumor necrosis factor-related apoptosis-inducing ligand receptor dr5, the producing method and uses thereof |
| 05/30/2007 | EP1790662A1 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 05/30/2007 | EP1789791A2 Busulfan immunoassay |
| 05/30/2007 | EP1789590A2 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 05/30/2007 | EP1789571A1 Production of polypeptides |
| 05/30/2007 | EP1789555A1 Novel regulation protein |
| 05/30/2007 | EP1789548A1 Antibody libraries |
| 05/30/2007 | EP1789451A2 Tie complex binding proteins |
| 05/30/2007 | EP1789450A1 Use of ilt6 for immunomodulation |
| 05/30/2007 | EP1789449A1 Anti-glycated cd59 antibodies and uses thereof |
| 05/30/2007 | EP1789448A2 PROTECTIVE ANTI-GLUCAN ANTIBODIES WITH PREFERENCE FOR ß-1,3-GLUCANS |
| 05/30/2007 | EP1789447A2 Method of delivering rna interference and uses thereof |
| 05/30/2007 | EP1789446A2 Heteromultimeric molecules |
| 05/30/2007 | EP1789093A2 Antibody vaccine conjugates and uses therefor |
| 05/30/2007 | EP1789087A2 Engineered antibody fragment that irreversibly binds an antigen |
| 05/30/2007 | EP1789086A2 Extended treatment of multiple sclerosis |
| 05/30/2007 | EP1601697B1 Antibody purification by Protein A and ion exchange chromatography |
| 05/30/2007 | EP1507859A4 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 05/30/2007 | EP1506235B1 Method for producing monoclonal antibodies |
| 05/30/2007 | EP1373487B1 Regulation of human protein kinase-like protein |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1292335B1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP1206274B1 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0885393B1 Graphitic nanotubes in luminescence assays |
| 05/30/2007 | CN1973205A Method of diagnosing lawsonia intracellularis |
| 05/30/2007 | CN1973053A Novel anti-IL 13 antibodies and uses thereof |
| 05/30/2007 | CN1973038A HCV RNA having novel sequence |
| 05/30/2007 | CN1972714A Methods of treating autoimmune and inflammatory diseases |
| 05/30/2007 | CN1972713A Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor |
| 05/30/2007 | CN1972712A Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist |
| 05/30/2007 | CN1970573A Neutrality monoclonal antibody 3E1 for resisting ricin, its preparation method and uses |
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1318596C Vectors based on recombinant defective viral gene group, and their use in formulation of vaccines |
| 05/30/2007 | CN1318591C Immune tbid gene and its coded protein and application |
| 05/30/2007 | CN1318589C Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 05/30/2007 | CN1318588C Osteoprotegerine |
| 05/30/2007 | CN1318450C Modified/chimeric super-antigens and their use |
| 05/30/2007 | CN1318449C Application of anti SARS specificity IgY in preparation dor preventing and treating SARS |
| 05/30/2007 | CN1318447C Tumor antigen peptides originating in cyclophilin B |
| 05/30/2007 | CN1318446C Transferrin receptor protein of Moraxella |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis |
| 05/29/2007 | US7223852 Nucleic acids encoding TRAIN-R: a cysteine rich member of the TNF-receptor family |
| 05/29/2007 | US7223848 Methods for purifying Fc-containing proteins |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223844 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes |
| 05/29/2007 | US7223841 Antibody for use in the diagnosi, prevention and treatment of cell proliferative disorders |
| 05/29/2007 | US7223840 Antimicrobial peptide |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223834 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
| 05/29/2007 | US7223729 Suppressing an immune response, CD200, a molecule with previously unknown function belonging to the Ig superfamily, is an immune suppressant; preventing graft rejection, fetal loss, autoimmune diseases, allergies |
| 05/29/2007 | US7223724 Administering a polypeptide attached to a water soluble polymer; treating age-related macular degeneration, diabetic retinopathy, peripheral vitreoretinopathies, photic retinopathies, surgery-induced retinopathies, viral retinopathies, ischemlc retinopathies, retinal detachment and traumatic retinopathy |
| 05/29/2007 | US7223586 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 05/29/2007 | US7223571 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 05/29/2007 | US7223565 for drug screening interleukins; expression in bacteria, yeast, plant, insect, and animal cells; genetic engineering |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223553 Immunoassays for everolimus |
| 05/29/2007 | US7223551 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants |
| 05/29/2007 | US7223549 Compositions for identification and isolation of stem cells |
| 05/29/2007 | US7223396 Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies |
| 05/29/2007 | US7223395 Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2 |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | US7223393 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents |
| 05/29/2007 | US7223392 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/24/2007 | WO2007059360A2 Oral use of specific antibodies for intestinal health |
| 05/24/2007 | WO2007059300A2 Anti-alk antagonist and agonist antibodies and uses thereof |
| 05/24/2007 | WO2007059234A1 Method for the treatment of pdgf-d related diseases using anit-pdgf-dd antibodies |
| 05/24/2007 | WO2007059203A2 Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors |
| 05/24/2007 | WO2007059188A1 Method for treating joint damage |
| 05/24/2007 | WO2007059082A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 05/24/2007 | WO2007058823A2 Anti-egfr antibodies |
| 05/24/2007 | WO2007058725A2 Engineered antibody fragment that irreversibly binds an antigen |
| 05/24/2007 | WO2007058588A1 Monoclonal antibodies against apolipoprotein m |
| 05/24/2007 | WO2007058267A1 Novel protein and gene encoding the protein |
| 05/24/2007 | WO2007057670A1 Nidogen/snep-iike molecule |
| 05/24/2007 | WO2007057062A1 Human bocavirus and methods of diagnosis and treatment |
| 05/24/2007 | WO2007056858A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | WO2007028259A3 Antigens for vaccination against and detection of mycoplasma suis |
| 05/24/2007 | WO2007023316A3 Assay for trypanosome infection |
| 05/24/2007 | WO2007014743A3 Cd33-specific single-chain immunotoxin and method of use |
| 05/24/2007 | WO2007009013A3 Methods and compositions related to a braf mutation and microsatellite stability |
| 05/24/2007 | WO2007008463A3 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 05/24/2007 | WO2006135912A3 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| 05/24/2007 | WO2006116192A3 Irta-1 antibodies and their uses |
| 05/24/2007 | WO2006100681A3 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |
| 05/24/2007 | WO2006029089A3 Tetrahydrocannabinoid- protein conjugates for the production of antibodies for the detection of tεtrahydrocannabinoid components in saliva |
| 05/24/2007 | WO2005123959A3 Multiplexing assays for analyte detection |
| 05/24/2007 | WO2005012484A3 Antibody-toxin conjugates |
| 05/24/2007 | US20070118934 Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax |
| 05/24/2007 | US20070117970 generating an immune response, comprising administering to a mammal variable major protein (VMP)-like polypeptides as antigens for immunoprophylaxis, immunotherapy and immunodiagnosis; antibodies; Lyme disease |